B3GAT1 and melanoma: A markedly immunotolerant tumor microenvironment (TME) has been observed in melanoma-bearing LN, with reduced and impaired NK cells and increased CD57+PD-1+CD8+T cells, leading to compromised anti-melanoma immunity and a high relapse rate18.